A. Weinzierl

发表

TAP-Independent MHC Class I Presentation

O. Lund, M. Nielsen, M. Larsen, 2006 .

Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.

S. Stevanović, A. Weinzierl, O. Planz, 2008, Vaccine.

Features of TAP‐independent MHC class I ligands revealed by quantitative mass spectrometry

Nina Hillen, Stefan Tenzer, H. Rammensee, 2008, European journal of immunology.

Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface*S

Hans-Georg Rammensee, Arnulf Stenzl, Dorothee Wernet, 2007, Molecular & Cellular Proteomics.

Effective Chemokine Secretion by Dendritic Cells and Expansion of Cross-Presenting CD4−/CD8+ Dendritic Cells Define a Protective Phenotype in the Mouse Model of Coxsackievirus Myocarditis

H. Rammensee, S. Stevanović, A. Weinzierl, 2008, Journal of Virology.

A novel MHC-associated Proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of myeloid leukaemias

S. Stevanović, A. Weinzierl, G. Pawelec, 2006, Leukemia.

Attack by Peptide-Specific CTL Protect Vascular Endothelial Cells from an Two Preferentially Expressed Proteins

L. Rohrer, S. Stevanović, A. Weinzierl, 2012 .

Effective Chemokine Secretion by Dendritic Cells and Expansion of Cross-Presenting CD4 (cid:2) /CD8 (cid:1) Dendritic Cells Deﬁne a Protective Phenotype in the Mouse Model of Coxsackievirus Myocarditis (cid:1)

S. Stevanović, A. Weinzierl, K. Klingel, 2008 .

Sustained nitric oxide synthesis contributes to immunopathology in ongoing myocarditis attributable to interleukin-10 disorders.

A. Weinzierl, K. Klingel, M. Sauter, 2006, The American journal of pathology.

Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA‐B44 supertype

Nina Hillen, Arnulf Stenzl, Dorothee Wernet, 2008, European journal of immunology.

A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays.

H. Rammensee, S. Stevanović, O. Schoor, 2008, Cancer research.

New approaches in tumour immunology: Implications from mass spectrometric analyses of HLA-ligands

A. Weinzierl, 2008 .

Identification of HLA-A*01- and HLA-A*02-restricted CD8+ T-cell epitopes shared among group B enteroviruses.

H. Rammensee, S. Stevanović, A. Weinzierl, 2008, The Journal of general virology.

Structure of a bifunctional DNA primase-polymerase

Claudia Buchen, Patrick Cramer, P. Cramer, 2004, Nature Structural &Molecular Biology.

A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma

A. Weinzierl, E. Noessner, D. Schendel, 2005, Journal of Translational Medicine.

HLA ligand profiles of primary renal cell carcinoma maintained in metastases

H. Rammensee, S. Stevanović, A. Weinzierl, 2009, Cancer Immunology, Immunotherapy.

Alteration of NF-κB activity leads to mitochondrial apoptosis after infection with pathological prion protein

A. Weinzierl, R. Schmid, O. Planz, 2007, Cellular microbiology.

A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma

A. Weinzierl, E. Noessner, D. Schendel, 2005, Journal of Translational Medicine.

Two Preferentially Expressed Proteins Protect Vascular Endothelial Cells from an Attack by Peptide-Specific CTL

A. von Eckardstein, L. Rohrer, S. Stevanović, 2012, The Journal of Immunology.

LC-MS-based Protein and Peptide Quantification Using Stable Isotope Labels: From ICAT in General to Differential N-terminal Coding (dNIC) in Particular

S. Stevanović, A. Weinzierl, 2006, Biotechnology & genetic engineering reviews.

A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays.

H. Rammensee, S. Stevanović, O. Schoor, 2008, Cancer research.